Keratosis pilaris (KP) is a skin condition that causes small, rough bumps, giving the skin a texture like gooseflesh. It commonly affects the arms, legs, and buttocks. (1) When Keratosis pilaris is linked to prolonged sun exposure and dry skin. It leads to bumpy, rough skin that can look red, feel itchy, and sometimes gets irritated or darker in some areas. (2)
Beside these current treatments for keratosis pilaris, like creams and oral medications, often don't work well long-term. Since it's a chronic condition, researchers are looking into new options like light and laser therapies that might work better. (3) Laser and light treatments have some of the strongest evidence backing them for treating keratosis pilaris. Specifically, the Nd:YAG laser is often preferred due to its longer wavelength.(4)
Glycolic acid, salicylic acid, and lactic acid can help with keratosis pilaris treatment. They work by exfoliating the skin, removing dead skin cells, and unclogging pores. This can improve skin texture and reduce bumps. Azelaic acid and retinoic acid are other options that can help smooth the skin and reduce hyperpigmentation. These acids can be effective in managing keratosis pilaris.(5)
Glycolic acid is commonly used in KP treatment with high-concentration glycolic acid showed effective treatment for keratosis pilaris. Improvement in keratotic papules was observed after the first session and increased with repeated treatments and higher concentrations. A 70% glycolic acid peel achieved about 92% effectiveness after four sessions. Perifollicular pigmentation improved after the second treatment, while erythema reduction appeared after the third. Overall, the treatment was safe and well tolerated. (6)
A study found that 10% lactic acid and 5% salicylic acid both improved keratosis pilaris, but lactic acid worked faster and showed more noticeable results. With lactic acid, improvements started at 4 weeks and kept getting better up to 12 weeks. By the end, over 62.5% of participants using lactic acid had significant improvement and clear skin.(7)
Azelaic acid helps reduce excessive keratin buildup in the skin by slowing down the growth of keratinocytes (skin cells). It works by reducing DNA synthesis, causing mild mitochondrial damage, and affecting cell structures such as the rough endoplasmic reticulum. It also decreases the production of keratin precursors, which prevents keratinocytes from fully maturing. By regulating the keratinization process in the epidermis, it helps control abnormal skin thickening and is widely used in dermatological treatments for Keratosis pilaris.
Urea is a natural component of the skin’s natural moisturizing factor (NMF) and plays a key role in maintaining epidermal hydration and barrier function. In dermatology, it is commonly used for its moisturizing and keratolytic properties. At lower concentrations (≤10%), urea mainly acts as a humectant, improving water retention in the stratum corneum and enhancing skin softness and flexibility. At higher concentrations (>10%), it demonstrates keratolytic activity by breaking hydrogen bonds in keratin, which helps loosen and soften compacted corneocytes. Topical formulations generally contain 10–30% urea, where lower concentrations are used for mild dryness and maintenance, while 20–30% formulations are often recommended for conditions associated with marked hyperkeratosis, such as keratosis pilaris (KP). (8)
Sirolimus, originally known for its antifungal properties, has shown to have antiproliferative and immunosuppressive effects. It works by targeting a specific protein, which helps reduce inflammation and hyperkeratosis. There's a case where topical sirolimus gel (0.2%) showed great results for keratosis pilaris, suggesting it could be a promising treatment option. (9)
Tazarotene is a topical treatment that targets skin cell growth and differentiation. It's been used for conditions like Darier's disease and ichthyosis, and was tried on 20 patients with keratosis pilaris. Applying 0.01% tazarotene cream nightly for 4-8 weeks led to significant improvement, with results visible in as little as 2 weeks. Since tazarotene has low absorption and is quickly metabolized, it might be a good option for keratosis pilaris and similar skin conditions.(10)
A new approach to treating keratosis pilaris combines scrubs and moisturizers to tackle the condition's dual issues: removing dead skin cells and repairing the skin barrier. The scrub helps remove keratin buildup, smoothing the skin, while the moisturizer hydrates and strengthens the skin. Studies show this combo can reduce roughness, redness, and pigmentation. A recent 28-day study tested a specific combo of a scrub with natural ingredients like olive shell powder and a moisturizing lotion with plant oils, aiming to improve skin texture and hydration in KP patients aged 18-39.(11)
Injectable hyaluronic acid (HA) has recently been used to improve skin quality. Unlike topical emollients that mainly act on the stratum corneum, HA injections can influence deeper skin layers, enhancing hydration and supporting the extracellular matrix important for fibroblast activity. Its strong water-binding ability and minimally invasive administration have contributed to its growing use in skin rejuvenation. While most dermatological studies have focused on HA for skin aging, this study evaluates non-cross-linked HA for the treatment of keratosis pilaris (KP). The findings suggest that injectable non-cross-linked HA may help improve skin roughness and textural irregularities associated with non-erythematous KP.(12)
For keratosis pilaris that's resistant to usual treatments, laser and light therapies can be an option. Pulsed dye laser targets redness by affecting blood vessels, while Nd:YAG laser improves bumps and pigmentation by penetrating deeper. Fractional CO₂ laser stimulates collagen and smooths skin texture, and Intense Pulsed Light (IPL) reduces redness and pigmentation. Other options like microdermabrasion and chemical peels can help with exfoliation, but results might be temporary and cause some irritation.(13)
